Back to search

University of Patras

Βιοχημική και κυτταρική in vitro και in vivo προσέγγιση της αντικαρκινικής δράσης του θειωμένου υαλουρονικού στον καρκίνο του μαστού

Abstract

dc:description

Breast cancer is one of the most prevalent malignancies worldwide, with disease progression largely depending on the expression of estrogen receptors (ERs), while the expression of extracellular matrix (ECM) molecules also plays a critical role. Hyaluronan (HA), a major component of the ECM, is involved in a plethora of physiological and pathological processes. Unlike other glycosaminoglycans, HA does not bear any substitutions to its structure naturally. However, recent studies highlight the use of chemically modified HA derivatives, such as sulfated hyaluronan (sHA), in applications including bio-scaffold manufacturing, wound healing, osteogenesis, and disease targeting. In the present PhD thesis, the effects of sHA on breast cancer cells of different ER status were studied. To this end, high-sulfated sHA was synthesized and its in vitro activity was evaluated on the breast cancer cell lines MCF-7, MDA-MB-231, Hs578T, and the stably transfected shERβ MDA-MB-231. Subsequently, three-dimensional in vitro cell culture models were developed and the effect of sHA was investigated under conditions that better reflect the tumor microenvironment. Moreover, the effect of sHA was studied in vivo in immunodeficient mice. Finally, the mechanism of action was investigated by studying signaling pathways, in addition to in silico molecular docking studies to predict possible interactions with HA receptors and degradation enzymes. According to the results, sHA reduces proliferation, migration, and invasion in the aggressive breast cancer cells, while increasing cell adhesion. Additionally, changes in cell morphology towards a more epithelial phenotype are observed through the use of scanning electron microscopy. These changes are further corroborated by alterations in the expression of important ECM molecules, as well as markers of cancer progression or suppression at the gene and protein level. Moreover, sHA reduces the tumorigenic capacity of breast cancer cells in immunodeficient mice. Overall, sHA demonstrates more potent antitumor activity compared to HA of the same molecular weight in both conventional and 3D cell cultures. This activity is primarily mediated through its main receptor, CD44, and partially attributed to competition with endogenously produced HA. In conclusion, the present thesis highlights the suppressive role of sHA in breast cancer, particularly in triple-negative breast cancer, thus marking it as a promising biomolecule in the development of innovative therapeutic approaches.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Koutsakis, Christos
  • Κουτσάκης, Χρήστος

Subjects

dc:subject × 19

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/56185

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Koutsakis, Christos; Κουτσάκης, Χρήστος. Βιοχημική και κυτταρική in vitro και in vivo προσέγγιση της αντικαρκινικής δράσης του θειωμένου υαλουρονικού στον καρκίνο του μαστού. University of Patras, 2024. http://hdl.handle.net/10442/hedi/56185